Clinical Trial Update: A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat doses of GSK3884464 in healthy partic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• GSK3884464

Snippet

Sponsor: GlaxoSmithKline | Conditions: Heart Failure | Phase 1 | Status: TERMINATED | Results posted: 2024-05-02